Genomelabs India Private Limited
About Genomelabs India Private Limited
Data last updated:
Genomelabs India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the real estate development and construction segment of the real estate and construction sector. It was incorporated on 23 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2004PTC044946.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3.53 Lakh. It was formerly known as Genomlabs India Private Limited. It is led by directors Nagaraju Pathapati and Lakshmi Dandu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No. 8 – 2 – 120/86/9/4/28 Plot No. 28 Rao & Raju Colony Banjara Hills, Hyderabad, Telangana, India – 500034.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Genomelabs India has one previous CIN (Corporate Identification Number): U24230AP2004PTC044946. The current CIN is U24230TG2004PTC044946, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2004PTC044946 | Current |
| U24230AP2004PTC044946 | Previous |
Contact details
Genomelabs India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressD.No. 8 – 2 – 120/86/9/4/28 Plot No. 28 Rao & Raju Colony Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryReal Estate and Construction, Real Estate Builders & Developers
To see the full contact details of Genomelabs India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Genomelabs India Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genomelabs India Private Limited, buy the company report.
Board of directors of Genomelabs India Private Limited
Genomelabs India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagaraju Pathapati Also directs: PNR Infra India Private Limited, Genomelabs Bio Private Limited | Director | 23 Dec 2004 | 21 Years 10 Months | Current |
| Lakshmi Dandu | Director | 15 Mar 2024 | 2 Years 7 Months | Current |
Shareholding
The shareholding of Genomelabs India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Genomelabs India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genomelabs India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genomelabs India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Genomelabs India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Genomelabs India Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Lakshmi Dandu ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Genomelabs India is an active private limited company based in Hyderabad, Telangana, India. The company works in real estate builders and developers, within the real estate and construction industry. It was incorporated on 23 December 2004 (22+ years old) and is registered under CIN U24230TG2004PTC044946.
Genomelabs India has 2 current directors:
- Nagaraju Pathapati - Director
- Lakshmi Dandu - Director
The latest financial statements of Genomelabs India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Genomelabs India is U24230TG2004PTC044946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genomelabs India was incorporated on 23 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lakshmi Dandu ceased to be Additional Director on 29 Sep 2024. Lakshmi Dandu was appointed as Director on 15 Mar 2024. Suresh Raju Patapati ceased to be Director on 15 Mar 2024. Genomelabs India has 4 board changes on record in total.
The registered office of Genomelabs India is at D.No. 8 – 2 – 120869428 Plot No. 28 Rao & Raju Colony Banjara Hills, Hyderabad, Telangana, India – 500034.
Genomelabs India operates in the real estate and construction industry, in the real estate builders and developers segment.
The compliance status of Genomelabs India is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Yes. Genomelabs India was formerly known as Genomlabs India Private Limited.